Eric Halioua

Eric Halioua was the founder of MYOSIX SA, founded in 2000, where the title held was Chief Executive Officer in 2002.
Mr. Halioua was the founder of PROMETHERA Biosciences SA, founded in 2009, where the title held was Chief Executive Officer from 2009 to 2015.
Mr. Halioua is also the founder of Murigenetics SAS..
Mr. Halioua is currently Co-President, Chief Executive Officer & Director at PDC Line Pharma SASU since 2016.
Mr. Halioua is Chairman at BioSenic SA starting in 2025.
Mr. Halioua is Director at European Biopharmaceutical Enterprises.
Mr. Halioua is Director at BioCuster.
Former positions include Chairman & Chief Executive Officer at PDC Line Pharma SA, Director at Vivalis SA, Non-Executive Director at Bioxodes SA, Project Leader at AstraZeneca PLC, and Principal at Arthur D.
Little, Inc. Education includes graduate degrees from ESSEC Business School and Université des Sciences et Technologies de Lille.